Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SCHENING, JENNIFER

NPI: 1619976560 · SOUTH ELGIN, IL 60177 · Pediatrics Physician · NPI assigned 07/21/2005

$1.37M
Total Medicaid Paid
32,575
Total Claims
27,524
Beneficiaries
31
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,276 $124K
2019 4,694 $186K
2020 6,143 $242K
2021 4,980 $219K
2022 4,349 $193K
2023 4,515 $190K
2024 4,618 $215K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6,182 5,098 $297K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3,470 2,844 $264K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,223 2,608 $235K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2,084 1,942 $157K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,141 1,789 $143K
96110 Developmental screening, with scoring and documentation, per standardized instrument 4,520 4,027 $72K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 773 713 $64K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,853 1,633 $28K
83655 1,647 1,319 $19K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 284 246 $14K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 746 478 $14K
99000 585 443 $13K
96127 1,177 1,082 $9K
99383 70 64 $6K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 63 61 $6K
85018 2,523 2,156 $6K
99382 59 38 $5K
87420 233 185 $3K
99381 34 27 $3K
87430 173 105 $3K
99349 34 28 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 26 21 $2K
99348 25 21 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 43 27 $1K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 12 12 $522.60
81002 75 74 $195.00
94760 101 84 $169.70
99177 16 15 $44.00
96161 323 307 $0.00
99072 68 65 $0.00
90460 Immunization administration through 18 years of age via any route, first or only component 12 12 $0.00